Michael Blash

Michael Blash serves as the Senior Vice President of Corporate Affairs, responsible for corporate communications and investor relations. Mr. Blash was most recently Senior Vice President at Blade Therapeutics, where he focused on communication strategy and investor relations aimed at advancing novel therapies for fibrosis and neurodegeneration. Prior to his tenure at Blade, Mr. Blash served as Vice President of Communications at The Medicines Company leading communications efforts to build a compelling value proposition for the company’s groundbreaking atherosclerosis therapy. Mr. Blash also spent nearly 20 years at Merck & Co. where he served in communications and marketing roles of increasing scope, ultimately reporting into the Chief Communications Officer as a member of the Global Communications Leadership Team, consistently delivering results for inline brands and investigational products and major corporate initiatives across the breadth of the company. Mr. Blash holds a bachelor's degree in Communication and English from La Salle University.